Russell 3000

LauraShawver

Dr. Laura Shawver Ph.D.

Silverback Therapeutics Dr. Laura Shawver is CEO of Synthorx, a company focused on optimizing protein therapeutics. Prior to joining Synthorx, she was CEO and director of Cleave Biosciences, CEO of

Dr. Laura Shawver Ph.D. Read More »

Silverback Therapeutics Dr. Laura Shawver is CEO of Synthorx, a company focused on optimizing protein therapeutics. Prior to joining Synthorx, she was CEO and director of Cleave Biosciences, CEO of

DianTaylor

Dian C. Taylor

Artesian Resources Dian C. Taylor is currently Chair, President and CEO of Artesian. Under Dian’s visionary leadership, Artesian has grown from serving water customers only in northern New Castle County,

Dian C. Taylor Read More »

Artesian Resources Dian C. Taylor is currently Chair, President and CEO of Artesian. Under Dian’s visionary leadership, Artesian has grown from serving water customers only in northern New Castle County,

Diane Sullivan 1

Diane M. Sullivan

Caleres Diane Sullivan, who has headed up six different companies is currently Chairman and CEO of Caleres. Calares is a leading footwear company that owns and operates a variety of

Diane M. Sullivan Read More »

Caleres Diane Sullivan, who has headed up six different companies is currently Chairman and CEO of Caleres. Calares is a leading footwear company that owns and operates a variety of

AlexandriaForbes

Dr. Alexandria Forbes Ph.D.

MeiraGTx Holdings plc Dr. Alexandria Forbes is founder, President and CEO of MeiraGTx, a vertically integrated, clinical stage gene therapy company. Prior to founding MeiraGTx, she served as senior vice

Dr. Alexandria Forbes Ph.D. Read More »

MeiraGTx Holdings plc Dr. Alexandria Forbes is founder, President and CEO of MeiraGTx, a vertically integrated, clinical stage gene therapy company. Prior to founding MeiraGTx, she served as senior vice

AthenaCountouriotis

Dr. Athena M. Countouriotis M.D.

Turning Point Therapeutics Dr. Athena Countouriotis, President, CEO, and board member of Turning Point Therapeutics has broad oncology biotech leadership experience, guiding multiple development programs to approval. Her experience includes

Dr. Athena M. Countouriotis M.D. Read More »

Turning Point Therapeutics Dr. Athena Countouriotis, President, CEO, and board member of Turning Point Therapeutics has broad oncology biotech leadership experience, guiding multiple development programs to approval. Her experience includes

CatherineCorrigan

Dr. Catherine Corrigan Ph.D.

Exponent Dr. Catherine Corrigan is President and CEO of Exponent. She joined the company in 1996, was promoted to principal in the Biomechanics Practice in 2002, and to corporate vice

Dr. Catherine Corrigan Ph.D. Read More »

Exponent Dr. Catherine Corrigan is President and CEO of Exponent. She joined the company in 1996, was promoted to principal in the Biomechanics Practice in 2002, and to corporate vice

CherylBlanchard

Dr. Cheryl R. Blanchard Ph.D.

Anika Therapeutics Dr. Cheryl Blanchard was appointed President and CEO of Anika Therapeutics, after serving as interim CEO. Anika specializes in the development, manufacture and commercialization of therapeutic pharmaceuticals and

Dr. Cheryl R. Blanchard Ph.D. Read More »

Anika Therapeutics Dr. Cheryl Blanchard was appointed President and CEO of Anika Therapeutics, after serving as interim CEO. Anika specializes in the development, manufacture and commercialization of therapeutic pharmaceuticals and

debra osteen 3

Debra K. Osteen

Acadia Healthcare Debra Osteen retired as CEO and Director of Acadia Healthcare in March 2022. Osteen’s skill, passion and vision helped many struggling patients and continue Acadia’s mission that sets

Debra K. Osteen Read More »

Acadia Healthcare Debra Osteen retired as CEO and Director of Acadia Healthcare in March 2022. Osteen’s skill, passion and vision helped many struggling patients and continue Acadia’s mission that sets

Register for this year’s Rethinking and Accelerating Women’s Leadership in Business Forum!